Tilray Inc (NASDAQ:TLRY) to Post FY2025 Earnings of ($0.05) Per Share, Alliance Global Partners Forecasts

Tilray Inc (NASDAQ:TLRY) – Analysts at Alliance Global Partners boosted their FY2025 EPS estimates for Tilray in a report released on Tuesday, July 30th. Alliance Global Partners analyst A. Grey now expects that the company will post earnings of ($0.05) per share for the year, up from their previous estimate of ($0.07). Alliance Global Partners has a “Neutral” rating and a $2.75 price objective on the stock. The consensus estimate for Tilray’s current full-year earnings is ($0.13) per share.

Tilray (NASDAQ:TLRY) last posted its quarterly earnings results on Monday, July 29th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by ($0.02). The business had revenue of $229.90 million during the quarter, compared to analyst estimates of $226.20 million. Tilray had a negative return on equity of 2.65% and a negative net margin of 30.26%. The company’s quarterly revenue was up 24.8% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.15) EPS.

TLRY has been the topic of several other reports. CIBC lowered their price objective on shares of Tilray from $2.25 to $2.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 10th. Canaccord Genuity Group lowered their price objective on shares of Tilray from $4.25 to $4.00 and set a “buy” rating on the stock in a research report on Wednesday, April 10th.

Tilray Trading Down 2.0 %

NASDAQ TLRY opened at $1.99 on Friday. Tilray has a twelve month low of $1.60 and a twelve month high of $3.40. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.18 and a current ratio of 1.92. The stock has a market cap of $1.54 billion, a price-to-earnings ratio of -4.52 and a beta of 2.19. The firm’s 50 day moving average price is $1.79 and its two-hundred day moving average price is $1.90.

Institutional Investors Weigh In On Tilray

Several institutional investors and hedge funds have recently modified their holdings of TLRY. Prospect Financial Services LLC acquired a new stake in shares of Tilray in the 2nd quarter valued at $26,000. Gainplan LLC acquired a new stake in shares of Tilray in the 4th quarter valued at $28,000. Simplicity Wealth LLC acquired a new stake in shares of Tilray in the 1st quarter valued at $28,000. RPO LLC acquired a new stake in shares of Tilray in the 4th quarter valued at $28,000. Finally, Wellington Wealth Strategies LLC. bought a new position in Tilray in the 4th quarter worth $29,000. Institutional investors and hedge funds own 9.35% of the company’s stock.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.